Transcript Document
CTSA REGULATORY KNOWLEDGE WORKGROUP
September 12, 2007
DTMI
representatives
Wesley Byerly, PharmD - Presenter
Bruce Burnett, PhD
Deborah Roth
Judith Kramer, MD
Jennifer Holcomb
Wajeeh Bajwa, PhD
Sue Avery
1
9/12/2007
Duke Translational
Medicine Institute
(DTMI)
Duke Translational
Organizational
Research Institute
Structure
(DTRI)
DTMI
Administration
Duke Clinical
Research Institute
(DCRI)
Duke Center for
Community Research
(DCCR)
Education and Training
Ethics
Pediatrics
Biomedical Informatics
Biostatistics
Nursing
Core Laboratories
Regulatory Affairs
Project Leaders and the Portal Office
Site Based Research (SBR)
Duke Clinical Research Unit (DCRU)
New molecule
First-in-human
2
Preclinical development
9/12/2007
Application in the community
Phase II / III
Initiatives
Site Based Research (SBR)
DCRI Regulatory Services and QA/RC
DTMI Regulatory Affairs
Research Review Process
3
9/12/2007
Vehicle for Organizing Site Based Research (SBR)
SBR Charters/Strategic Plan
Study evaluation and selection processes
Coordination of Site Initiation activities
Financial management and accountability/billing
activities
Personnel management
Communication activities
Annual reports
Subject Registry
QA (GCP and financial)
4
9/12/2007
DCRI Regulatory Services and
Quality Assurance and Regulatory Compliance
DCRI Regulatory Services
Preparation, regulatory filing, and maintenance of
drug and device clinical trial applications
Regulations regarding submissions and clinical
trials
Resource for GMP testing, validation
Resource for CMC content and writing of CMC
sections for INDs as needed (e.g. when new dosage
forms or placebos are required)
Fully developed Quality Assurance and
Regulatory Compliance function
5
9/12/2007
DTMI Regulatory Affairs
Consulting and project planning throughout
full translational cycle
IND/IDE Preparation, regulatory filing, and
maintenance of drug and device clinical trial
applications
Draft Institutional Policy for IND/IDE
submissions
Develop tools and resources for PIs
6
9/12/2007
Research Process Review
Process Mapping
Identify improvement opportunities
Optimize operational and time efficiencies
Implement identified process changes
7
9/12/2007
Additional Current Initiatives
Centralized focus for Translational Pilot
Projects
Outside consulting for key functions
Pilot Projects
Technology Cores (e.g. Cell Therapy)
Regulatory support for technology core
initiatives (imaging, biorepository, genomics)
Reshape Research Subject Advocacy function
Multi-national project support
8
9/12/2007
Barriers and Challenges
Culture change
Streamlining business processes
Determining scope of decentralized regulatory
support
Pre-clinical development
9
9/12/2007
Thank You for Your Attention
10
9/12/2007